|
Volumn 116, Issue 5, 2016, Pages 472-473
|
Rituximab in a patient with splenic marginal zone lymphoma and acquired angioedema
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BRADYKININ B2 RECEPTOR ANTAGONIST;
COMPLEMENT COMPONENT C1S INHIBITOR;
RITUXIMAB;
AUTOANTIBODY;
COMPLEMENT;
IMMUNOLOGICAL ANTINEOPLASTIC AGENT;
ACQUIRED ANGIOEDEMA;
AGED;
ANGIONEUROTIC EDEMA;
ARTICLE;
BONE MARROW BIOPSY;
CASE REPORT;
DISEASE SEVERITY;
ELECTROPHORESIS;
FEMALE;
HOSPITALIZATION;
HUMAN;
HUMAN TISSUE;
MAINTENANCE THERAPY;
MEDICAL HISTORY;
MONOCLONAL IMMUNOGLOBULINEMIA;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
SPLENIC MARGINAL ZONE LYMPHOMA;
SPLENOMEGALY;
BLOOD;
MALE;
MARGINAL ZONE LYMPHOMA;
SPLEEN TUMOR;
AGED;
ANGIOEDEMA;
ANTINEOPLASTIC AGENTS, IMMUNOLOGICAL;
AUTOANTIBODIES;
COMPLEMENT SYSTEM PROTEINS;
FEMALE;
HUMANS;
LYMPHOMA, B-CELL, MARGINAL ZONE;
MALE;
RITUXIMAB;
SPLENIC NEOPLASMS;
|
EID: 84969581122
PISSN: 10811206
EISSN: 15344436
Source Type: Journal
DOI: 10.1016/j.anai.2016.03.003 Document Type: Article |
Times cited : (4)
|
References (9)
|